ROBERT YAP: Open Payments
NPI 1154651933 · BURIEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 49 payments from 13 companies in 2025. Trend: 2023 $994 · 2024 $1,049 · 2025 $1,183
Food & beverage: $1,073Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $242 |
| ABBVIE INC. | 10 | $198 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Lilly USA, LLC | 6 | $144 |
| GlaxoSmithKline, LLC. | 5 | $109 |
| Exact Sciences Corporation | 3 | $90 |
| Amgen Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Braeburn Inc. | 2 | $47 |
| Lundbeck LLC | 1 | $32 |
Products named: AUSTEDO XR, MOUNJARO, AIRSUPRA, Cologuard Collection Kit, TRELEGY ELLIPTA, UBRELVY, QULIPTA, BREZTRI.
Industry payments across WA — which companies pay providers there.
